Neurochemical changes in rat striatum and substantia nigra following drug administration

The effects of a number of drugs that deplete catecholamines or block their receptors were investigated on the levels of free amino acids and glutamate decarboxylase activity in rat striatum and substantia nigra, in an attempt to clarify the possible links between catecholamine and amino acid transmitter function. While none of the drugs tested were significantly active in the striatum, profound changes occurred in the substantia nigra. The data are discussed in relation to the possible mechanisms involved.     

Dopamine-sensitive adenylate cyclase and cAMP phosphodiesterase in substantia nigra and corpus striatum of rat brain.

A dopamine-sensitive adenylate cyclase has been identified in substantia nigra of the rat brain. Low concentrations of dopamine markedly increased the accumulation of cyclic AMP while l-norepinephrine and isoproterenol had little effect at concentrations up to 100 μM. The phenothiazine, trifluoperazine, is a potent inhibitor of the s. nigral adenylate cyclase (I.C.₅₀ of 0.1 μM), while the adrenergic receptor blocking agents propranolol and phentolamine are ineffective. Basal activity of striatal adenylate cyclase and cAMP phosphodiesterase is approximately 3-fold higher than that found in substantia nigra.     

Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra

Glial cell line-derived neurotrophic factor (GDNF) improves motor dysfunction associated with aging in rats and non-human primates, in animal models of Parkinson's disease, and may improve motoric function in patients with advanced Parkinson's disease. These improvements are associated with increased dopamine function in the nigrostriatal system, but the molecular events associated with this increase are unknown. In these studies, 100 micro g of GDNF was injected into the striatum of normal aged (24-month-old) male Fischer 344 rats. The protein levels and phosphorylation of TH, ERK1/2, and related proteins were determined by blot-immunolabeling of striatum and substantia nigra harvested 30 days after injection. In GDNF-treated rats, TH phosphorylation at Ser31 increased approximately 40% in striatum and approximately 250% in the substantia nigra. In the substantia nigra, there was a significant increase in ERK1 phosphorylation. In striatum, there was a significant increase in ERK2 phosphorylation. Microdialysis studies in striatum showed that both amphetamine- and potassium-evoked dopamine release in GDNF recipients were significantly increased. These data show that GDNF-induced increases in dopamine function are associated with a sustained increase in TH phosphorylation at Ser31, which is greatest in the substantia nigra and maintained for at least one month following a single striatal administration of GDNF. These findings, taken from the nigrostriatal system of normal aged rats, may help explain the long lasting effects of GDNF on dopamine function and prior studies supporting that a major effect of GDNF involves its effects on dopamine storage and somatodendritic release of dopamine in the substantia nigra.     

Synapses in the rat substantia nigra

The composition and organization of the input to the rat substantia nigra were studied with the electron microscope. Four distinct types of synaptic boutons were described. The first contained small (381 A), clear synaptic vesicles. The second type contained the small, clear vesicles and several large, dense-core vesicles. The third ending contained large, dense-core vesicles and larger (581 A) clear vesicles. The fourth ending, found on the axon hillock and other terminal boutons, contained slightly elongated, clear synaptic vesicles. The presence of these four boutons was discussed in light of the known afferent input and neurochemical composition of the substantia nigra.     

Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice

Acute administration of repeated doses of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) dramatically reduces striatal dopamine (DA) content, tyrosine hydroxylase (TH), and DA transporter-immunoreactivity in mice. In this study, we show for the first time the spatiotemporal pattern of dopaminergic damage and related molecular events produced by MDMA administration in mice. Our results include the novel finding that MDMA produces a significant decrease in the number of TH-immunoreactive neurons in the substantia nigra (SN). This decrease appears 1 day after injection, remains stable for at least 30 days, and is accompanied by a dose-dependent long-lasting decrease in TH- and DA transporter-immunoreactivity in the striatum, which peaked 1 day after treatment and persisted for at least 30 days, however, some recovery was evident from day 3 onwards, evidencing sprouting of TH fibers. No change is observed in the NAc indicating that MDMA causes selective destruction of DA-containing neurons in the nigrostriatal pathway, sparing the mesolimbic pathway. The expression of Mac-1 increased 1 day after MDMA treatment and glial fibrillary acidic protein increased 3 days post-treatment in the striatum and SN but not in the NAc, in strict anatomical correlation with dopaminergic damage. These data provide the first evidence that MDMA causes persistent loss of dopaminergic cell bodies in the SN.     

Impact of aging on heat shock protein expression in the substantia nigra and striatum of the female rat

Many heat shock proteins are chaperones that help refold or degrade misfolded proteins and battle apoptosis. Because of their capacity to protect against protein misfolding, they may help keep diseases of aging at bay. A few reports have examined heat shock proteins (eg. Hsp25, Hsp60, Hsp70, and heat shock cognate 70 or Hsc70) as a function of age in the striatum and nigra. In the present study, we examined the impact of aging on Hsp25, heme oxygenase 1 (HO1 or Hsp32), Hsp40, Hsp60, Hsc70, Hsc/Hsp70 interacting protein (Hip), 78 kDa glucose-regulated protein (GRP78), Hsp90, and ubiquitinated proteins in the nigra and striatum of the female rat by infrared immunoblotting. Female animals are not typically examined in aging studies, adding further to the novelty of our study. Striatal HO1 and Hsp40 were both higher in middle-aged females than in the oldest group. Hsp60 levels were also highest in middle age in the nigra, but were highest in the oldest animals in the striatum. Striatal levels of Hsc70 and the co-chaperone Hip were lower in the oldest group relative to the youngest animals. In contrast, Hsp25 rose with advancing age in both regions. Hsp25 was also colocalized with tyrosine hydroxylase in nigral neurons. Ubiquitinated proteins exhibited a trend to rise in the oldest animals in both regions, and K48 linkage-specific ubiquitin rose significantly from 4–6 to 16–19 months in the striatum. Our study reveals a complex array of age-related changes in heat shock proteins. Furthermore, the age-related rises in some proteins, such as Hsp25, may reflect endogenous adaptations to cellular stress.     

大鼠黑质多巴胺能神经元的二型性

成年哺乳动物的某些脑区存在性别差异,即二型性,但中脑黑质是否存在性分化目前不清楚。本文旨在探讨成年大鼠中脑黑质是否存在二型性。将60只成年大鼠分成5组：（1）正常雌鼠对照组：（2）正常雄鼠对照组：（3）去卵巢组;（4）去睾丸组;（5）去卵巢后回补雌激素组,该组大鼠在去卵巢后的第7天开始连续3d给予生理剂量的雌激素回补。所有大鼠在右侧黑质埋置记录电极,在清醒和安静的生理状态下连续14d记录黑质的P50听觉诱发电位（P50）,之后作黑质酪氨酸羟化酶（tyrosine hydroxylase,TH）免疫组织化学染色,检查TH阳性（TH^＋）细胞数量和形态变化。结果表明,正常成年雄鼠黑质的TH^＋细胞数量较雌鼠少22．47％（P〈0．05）,P50的T／C值也低34．72％（P〈0．01）,提示正常成年大鼠黑质在结构和功能上存在二型性。与正常雄鼠相比,去睾丸大鼠黑质的TH^＋细胞数量、形态和P50的T／C值无显著性变化（P〉0．05）。与正常雌鼠相比,去卵巢大鼠黑质TH^＋细胞数量减少28．09％（P〈0．01）,P50的T／C值降低30．85％（P〈0．01）。在大鼠去卵巢后的短时间内给予3d生理剂量的雌激素,15-20d后可观察到其黑质TH^＋细胞数量、形态和P50的T／C值基本恢复到去卵巢前水平。结果提示,大鼠中脑黑质的多巴胺能神经元在数量、结构和功能活动上存在性别差异：内源性雌激素在维持黑质多巴胺系统完整性及调节其功能活动中起重要作用。     

The fine structure of the neurons in the rat substantia nigra

Three distinct neurons were identified in the substantia nigra of the rat using Golgi, light, and electron microscopic techniques. A large neuron, found in the pars reticulata, is characterized by well-developed RER, a tubular cytoplasmic inclusion, and somatic and dendritec thorns. A medium-sized neuron, found in the pars compacta, has an eccentric nucleus, distinct Nissl bodies, and an inclusion composed of whorls of concentric cisternae. A small neuron, found in both nigral regions, contains a highly invaginated nucleus, fibrous nuclear inclusion, and paucity of cytoplasmic organelles. Its axon synapses around other nigral dendrites. The presence of these neurons was correlated with the efferent projections and function of the substantia nigra.     

Co-cultivation of astroglial enriched cultures from striatum and neuronal containing cultures from substantia nigra

A co-cultivation system was developed with neuron-containing (neuron-specific enolase (NSE) positive) primary cultures from the substantia nigra of 15 to 17-day old embryonic rats which were grown 1 mm apart from astroglial-enriched (glial fibrillary acidic protein (GFAp) positive) primary cultures from the striatum of neonatal rats. The astroglial cells went through a morphological differentiation with extension of processes after co-cultivation with the immunohistochemically-identified neuronal cells. The astroglial-enriched striatum cultures showed a higher active uptake of 3H-L-glutamate after co-cultivation for one week, compared to control cultures from striatum. Vmax (nmol X mg protein-1 X min-1 X was 58.4 +/- 8.3 after co-cultivation and 37.2 +/- 6.3 for control cultures. The glutamine synthetase (GS) activity was slightly increased after co-cultivation. The validity and specificity of the results were ensured. The data suggest that astroglial cells in a primary culture are influenced by co-cultivation with fetal neuron containing cultures resulting in morphological differentiation, and increases in 3H-L-glutamate uptake and GS activity.     

Differentiation gradient of dopaminergic neurons in substantia nigra of rat

The chemical differentiation featured by the appearance of tyrosine hydroxylase (TH) and the distribution pattern of the dopaminergic cells of rat substantia nigra (SN) were studied with combined immunocytochemical and electronmicroscopic techniques. Under the light microscope, the earliest TH-positive cells at embryonic day 13 are localized at the ventral part of rostral midbrain. Later appearing TH-positive cells join the earlier ones dorsally and caudally. As to the stain intensity and morphology of the labeled cells in the region of the SN, there exists a ventral to dorsal and lateral to medial spatiotemporal gradient, namely the cells in the ventral and lateral parts, compared with the dorsal and medial ones, have more intense staining, larger cell bodies with smaller nuclei and more and longer processes. The earliest nigrostriatal projection fibers stem from the most laterally located SN cells. Under electron microscope, rough endoplasmic reticula are always seen within the positively stained cells. With the progression of development, the cells show more intense staining and contain more rough endoplasmic reticula and other organelles. Together with the results reported on the neurogenesis and migration of the SN cells, the present study indicates that the chemical differentiation of SN cells, with a spatiotemporal gradient, starts after the completion of cell migration, a process paralleling to their morphological differentiation.     

Innervation of the substantia nigra

This review describes inputs to neurons in the substantia nigra and contrasts them with the action of agonists for the putative receptors through which they act. Special emphasis is placed on gamma-aminobutyric acid (GABA) afferents. Dopamine released from the somato-dendritic compartment of dopamine neurons and endocannabinoids released from dopamine and GABA neurons serve as retrograde signals to modulate GABA release. The release may be fostered by Ca²⁺ release from intracellular Ca²⁺ stores, which in turn may be influenced by the inputs.The studies summarized in this review were supported by the Deutsche Forschungsgemeinschaft (FOR 302/TP-B1)     

Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse

In the present report, fast-scan cyclic voltammetry was used to identify the monoamines that were released by electrical stimulation in mouse brain slices containing ventral tegmental area (VTA), substantia nigra (SN) -pars compacta (SNc) and -pars reticulata (SNr). We showed that voltammograms obtained in mouse VTA were consistent with detection of a catecholamine, while those in both subregions of the SN were consistent with detection of an indolamine, based on the reduction peak potentials. We used pharmacological blockade and genetic deletion of monoamine transporters to further confirm the identity of released monoamines in mouse midbrain and to assess the control of monoamines by their transporters in each brain region. Inhibition of dopamine and norepinephrine transporters by nomifensine (1 and 10 microm) decreased uptake rates in the VTA, but did not change uptake rates in either subregion of the SN. Serotonin transporter inhibition by fluoxetine (10 microm) decreased uptake rates in the SNc and SNr, but was without effect in the VTA. Selective inhibition of the norepinephrine transporter by desipramine (10 microm) had no effect in any brain region. Using dopamine transporter- and serotonin transporter-knockout mice, we found decreased uptake rates in VTA and SN subregions, respectively. Peak signals recorded in each midbrain region were pulse number dependent and exhibited limited frequency dependence. Thus, dopamine is predominately detected by voltammetry in mouse VTA, while serotonin is predominately detected in mouse SNc and SNr. Furthermore, active uptake occurs in these areas and can be altered only by specific uptake inhibitors, suggesting a lack of heterologous uptake. In addition, somatodendritic dopamine release in VTA was not mediated by monoamine transporters. This work offers an initial characterization of voltammetric signals in the midbrain of the mouse and provides insight into the regulation of monoamine neurotransmission in these areas.     

Two different types of dynorphin-A-immunoreactive terminals in rat substantia nigra

Summary The opioid peptide dynorphin A (1–17) is the third transmitter identified in the striatonigral projection, the other two being gamma-aminobutyric acid (GABA) and substance P. The ultrastructural features of the dynorphinergic terminals in substantia nigra/pars reticulata were studied using pre-embedding immunocytochemistry with the classical peroxidase-antiperoxidase-diaminobenzidine-method; these features were compared with GABAergic boutons visualized with an immunogold method. Two distinct types of dynorphin-A-immunoreactive boutons could be identified: (1) type A (81%) possessing characteristics similar to the GA-BAergic nerve endings in this region, i.e., large pleomorphic vesicles and symmetric synaptic contacts, (2) type B (19%) displaying asymmetric synaptic zones and small, mostly round vesicles. These results are in agreement with physiological studies suggesting a dual action of dynorphin A in substantia nigra.